Erin Quirk
2020
In 2020, Erin Quirk earned a total compensation of $3.8M as President and Chief Medical Officer at Terns Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $175,064 |
|---|---|
| Option Awards | $3,294,044 |
| Salary | $374,325 |
| Total | $3,843,433 |
Quirk received $3.3M in option awards, accounting for 86% of the total pay in 2020.
Quirk also received $175.1K in non-equity incentive plan and $374.3K in salary.
Rankings
In 2020, Erin Quirk's compensation ranked 2,977th out of 13,090 executives tracked by ExecPay. In other words, Quirk earned more than 77.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,977 out of 13,090 | 77th |
Division Manufacturing | 1,158 out of 5,624 | 79th |
Major group Chemicals And Allied Products | 434 out of 2,257 | 81st |
Industry group Drugs | 376 out of 1,957 | 81st |
Industry Pharmaceutical Preparations | 278 out of 1,462 | 81st |
Source: SEC filing on April 29, 2022.
Quirk's colleagues
We found two more compensation records of executives who worked with Erin Quirk at Terns Pharmaceuticals in 2020.